Quick Discovery Metabolomics
Powered by high-resolution reflector mass spectrometry, 3D micro/nano-structured mass spectrometry chips, and specialized small-molecule pretreatment kits, the next-generation untargeted metabolomics platform—Quick Discovery (Metabolomics)—enables high-throughput and highly stable enrichment and detection of small-molecule metabolites across diverse biological samples.
It supports comprehensive metabolic profiling in perturbed biological systems, including clinical matrices such as serum/plasma, urine, saliva, aqueous humor, cerebrospinal fluid, cells, and tissues.
This platform is ideal for applications such as biomarker discovery, molecular subtyping, drug sensitivity prediction, and therapeutic response monitoring.
Product Consultation
High Throughput:(1)Automated sample preparation: <2 hours for 96 samples (2)Automated spotting:<5 minutes for 96 samples (3)Automated detection::<30 minutes for 96 samples
High Stability and Reproducibility:(1)Inter-batch coefficient of variation (CV) maintained within 20% (2)Tight clustering of QC sample data with high overlap across confidence intervals